Status:
COMPLETED
An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%
Lead Sponsor:
Galderma R&D
Conditions:
Rosacea
Eligibility:
FEMALE
20-75 years
Brief Summary
The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.
Detailed Description
Evaluate the relationship between treatment with MetroGel® 1% and cosmetic performance with the Subjects' usual cosmetic products. It is expected that the female subjects will be able to use their rou...
Eligibility Criteria
Inclusion
- Subjects with moderate Rosacea (Global Severity Score of 3),
- Subjects willing to stop their current rosacea medication for at least 2 weeks
- Subjects must have an established routine of cosmetics application (e.g. must have been using the same facial foundation for at least 3 months and it is not expected to change during the study)
- Subjects must be willing to use their routine facial foundation and not change products while on study
Exclusion
- Subjects who do not routinely wear facial foundation
- Subjects who failed to undergo a washout period of 14 days for the use of topical rosacea therapy, (for example: metronidazole, azelaic acid, sulfacetamide)
- Subjects who are unwilling to stop their current rosacea medications for 2 weeks
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00668655
Start Date
February 1 2008
End Date
March 1 2008
Last Update
July 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Consulting Services
High Point, North Carolina, United States, 27262